Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular Oxytocin for Sensory Function in UV Burn Injury
NCT03935399Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Aug 2019
- Primary completion
- Mar 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxytocin in chronic pain (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoints: Change in Vibration Frequency Detection Threshold (When Vibration is First Felt), Change in Pain Threshold to a Punctate Mechanical Stimulus and 2 more. Started Aug 2019; status: completed.
02
Drugs
oxytocin
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT03935399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03935399.